Brightmind.ai

About:

Personalized brain stimulation brought to everyday life. A novel, effective approach to migraine prevention at home.

Website: https://brightmind.ai

Top Investors: xista science ventures

Description:

Millions of people worldwide suffer from brain-related issues that can already be addressed with the latest breakthroughs in neurotechnology at-home. We leverage cutting edge research to develop drastically better solutions for the greatest challenges to brain health. AI powered, personalized Neurotech Our vision is that Brightmind.AI’s personalized brain stimulation solutions are available in homes worldwide, offering to address globally important challenges to brain health such as pain relief, preventing cognitive decline and treating depression. Our first Use Case – Migraine Current solutions fail to achieve satisfactory outcomes: about 25% of 80 million migraineurs in the US and Europe are dissatisfied with existing treatment options. Research indicates that the stimulation protocol we use reduces migraine attacks by over 50%, for up to 90% of migraineurs.

Total Funding Amount:

$3.04M

Headquarters Location:

Vienna, Wien, Austria

Founded Date:

2022-01-01

Contact Email:

info(AT)brightmind.ai

Founders:

Florian Lerchbammer-Kreith, Gregor Kowarik, Rene Gilvert, Tamara Gerbert

Number of Employees:

1-10

Last Funding Date:

2024-05-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai